Promising Milestone in Neurodegenerative Disease Treatment: Vaxxinity’s UB-312 in Parkinson’s Patients
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) announced positive Phase 1 clinical trial results for...
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) announced positive Phase 1 clinical trial results for...
By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) said it plans to conduct a clinical trial...
By Daniella Parra Psychotropic industry innovator Lucy Scientific Discovery Inc. (Nasdaq: LSDI), has appointed Richard...
By Daniella Parra Marti Technologies Inc. announced that its Class A Ordinary Shares and warrants...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) announced the appointment of Brant Binder, a seasoned leader...
By Daniella Parra On Holding AG (NYSE: ONON) said it is opening a new store...
By Daniella Parra A recent survey by ProSomnus, Inc. (NASDAQ: OSA) and Proedge revealed that...
By Daniella Parra Prenetics Global Limited (NASDAQ: PRE) and Prof. Dennis Lo, the Li Ka...
Nationally relevant news stories frequently carry financial significance as well. Recently, Mark Hauser’s Hauser...
By Daniella Parra Swiss life sciences company Lunaphore Technologies SA has agreed to be acquired...